Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9BYX4 (IFIH1_HUMAN)

Last modified June 16, 2009. Version 70. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Interferon-induced helicase C domain-containing protein 1
    EC=3.6.1.-
Alternative name(s):
    Interferon-induced with helicase C domain protein 1
    Helicase with 2 CARD domains
      Short name=Helicard
    Melanoma differentiation-associated protein 5
      Short name=MDA-5
    RNA helicase-DEAD box protein 116
    Murabutide down-regulated protein
Gene names
Name: IFIH1
Synonyms: MDA5, RH116
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1025 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

RNA helicase that, through its ATP-dependent unwinding of RNA, may function to promote message degradation by specific RNases. Seems to have growth suppressive properties. Involved in innate immune defense against viruses. Upon interaction with intracellular dsRNA produced during viral replication, triggers a transduction cascade involving MAVS/IPS1, which results in the activation of NF-kappa-B, IRF3 and IRF7 and the induction of the expression of antiviral cytokines such as IFN-beta and RANTES (CCL5). ATPase activity is specifically induced by dsRNA. Essential for the production of interferons in response to picornaviruses. Ref.2

Subunit structure

Interacts with MAVS. Interacts with V protein of Simian virus 5, Human parainfluenza virus 2, Mumps virus, Sendai virus and Hendra virus. Binding to paramyxoviruses V proteins prevents IFN-beta induction, and the further establishment of an antiviral state. Ref.7 Ref.8 Ref.9

Subcellular location

Cytoplasm. Nucleus Potential. Note: May be found in the nucleus, during apoptosis.

Tissue specificity

Widely expressed, at a low level. Expression is detected at slightly highest levels in placenta, pancreas and spleen and at barely levels in detectable brain, testis and lung. Ref.2 Ref.1 Ref.5

Induction

By IFN-beta and TNF-alpha. Ref.1

Post-translational modification

During apoptosis, processed into 3 cleavage products. The helicase-containing fragment, once liberated from the CARD domains, translocate from the cytoplasm to the nucleus. The processed protein significantly sensitizes cells to DNA degradation By similarity.

Involvement in disease

Genetic variation in IFIH1 is associated with insulin-dependent diabetes mellitus 19 (IDDM19) [MIM:610155].

Miscellaneous

In HIV-1 infected HeLa-CD4 cells, overexpression of IFIH1 results in a great increase in the level of secreted viral p24 protein.

Sequence similarities

Belongs to the helicase family.

Contains 2 CARD domains.

Contains 1 helicase ATP-binding domain.

Contains 1 helicase C-terminal domain.

Sequence caution

The sequence AAH78180.1 differs from that shown. Reason: Miscellaneous discrepancy. Contaminating sequence. Potential poly-A sequence.

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q9BYX4-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q9BYX4-2)

The sequence of this isoform differs from the canonical sequence as follows:
     208-221: EIENLSQVDGPQVE → GICNFTEEDSSNSA
     222-1025: Missing.
Note: No experimental confirmation available.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 10251025Interferon-induced helicase C domain-containing protein 1
PRO_0000102012

Regions

Domain7 – 9791CARD 1
Domain110 – 19081CARD 2
Domain316 – 509194Helicase ATP-binding
Domain700 – 882183Helicase C-terminal

Sites

Site208 – 2092Cleavage By similarity
Site216 – 2172Cleavage By similarity
Site251 – 2522Cleavage By similarity

Amino acid modifications

Modified residue2891Phosphoserine By similarity
Modified residue3011Phosphoserine By similarity
Modified residue6451Phosphoserine By similarity

Natural variations

Alternative sequence208 – 22114EIENL…GPQVE → GICNFTEEDSSNSA in isoform 2.
VSP_013337
Alternative sequence222 – 1025804Missing in isoform 2.
VSP_013338
Natural variant4601H → R: dbSNP rs10930046.
VAR_031226
Natural variant8431H → R: dbSNP rs3747517. Ref.2 Ref.3 Ref.4
VAR_021594
Natural variant9461A → T Associated with susceptibility to insulin-dependent diabetes mellitus. dbSNP rs1990760. Ref.3 Ref.4 Ref.11
VAR_021595

Experimental info

Mutagenesis2511D → A: No cleavage and no acceleration of DNA degradation. Ref.5
Mutagenesis4441E → A: No acceleration of DNA degradation, no binding to ATP, and no helicase activity. Ref.5
Sequence conflict4391L → F in AAG54076. Ref.2
Sequence conflict4751N → H in BAB71141. Ref.4
Sequence conflict5921E → K in AAG34368. Ref.1
Sequence conflict5981R → S in AAG54076. Ref.2
Sequence conflict6091E → K in AAG54076. Ref.2
Sequence conflict7821K → R in BAB71141. Ref.4

Secondary structure

.............................. 1025
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified March 20, 2007. Version 3.
Checksum: 789CFB4824B92DC9

FASTA1,025116,689
        10         20         30         40         50         60 
MSNGYSTDEN FRYLISCFRA RVKMYIQVEP VLDYLTFLPA EVKEQIQRTV ATSGNMQAVE 

        70         80         90        100        110        120 
LLLSTLEKGV WHLGWTREFV EALRRTGSPL AARYMNPELT DLPSPSFENA HDEYLQLLNL 

       130        140        150        160        170        180 
LQPTLVDKLL VRDVLDKCME EELLTIEDRN RIAAAENNGN ESGVRELLKR IVQKENWFSA 

       190        200        210        220        230        240 
FLNVLRQTGN NELVQELTGS DCSESNAEIE NLSQVDGPQV EEQLLSTTVQ PNLEKEVWGM 

       250        260        270        280        290        300 
ENNSSESSFA DSSVVSESDT SLAEGSVSCL DESLGHNSNM GSDSGTMGSD SDEENVAARA 

       310        320        330        340        350        360 
SPEPELQLRP YQMEVAQPAL EGKNIIICLP TGSGKTRVAV YIAKDHLDKK KKASEPGKVI 

       370        380        390        400        410        420 
VLVNKVLLVE QLFRKEFQPF LKKWYRVIGL SGDTQLKISF PEVVKSCDII ISTAQILENS 

       430        440        450        460        470        480 
LLNLENGEDA GVQLSDFSLI IIDECHHTNK EAVYNNIMRH YLMQKLKNNR LKKENKPVIP 

       490        500        510        520        530        540 
LPQILGLTAS PGVGGATKQA KAEEHILKLC ANLDAFTIKT VKENLDQLKN QIQEPCKKFA 

       550        560        570        580        590        600 
IADATREDPF KEKLLEIMTR IQTYCQMSPM SDFGTQPYEQ WAIQMEKKAA KEGNRKERVC 

       610        620        630        640        650        660 
AEHLRKYNEA LQINDTIRMI DAYTHLETFY NEEKDKKFAV IEDDSDEGGD DEYCDGDEDE 

       670        680        690        700        710        720 
DDLKKPLKLD ETDRFLMTLF FENNKMLKRL AENPEYENEK LTKLRNTIME QYTRTEESAR 

       730        740        750        760        770        780 
GIIFTKTRQS AYALSQWITE NEKFAEVGVK AHHLIGAGHS SEFKPMTQNE QKEVISKFRT 

       790        800        810        820        830        840 
GKINLLIATT VAEEGLDIKE CNIVIRYGLV TNEIAMVQAR GRARADESTY VLVAHSGSGV 

       850        860        870        880        890        900 
IEHETVNDFR EKMMYKAIHC VQNMKPEEYA HKILELQMQS IMEKKMKTKR NIAKHYKNNP 

       910        920        930        940        950        960 
SLITFLCKNC SVLACSGEDI HVIEKMHHVN MTPEFKELYI VRENKALQKK CADYQINGEI 

       970        980        990       1000       1010       1020 
ICKCGQAWGT MMVHKGLDLP CLKIRNFVVV FKNNSTKKQY KKWVELPITF PNLDYSECCL 


FSDED 

« Hide

Isoform 2.

Checksum: 3C7139ECAC564BB5
Show »

FASTA22125,129

References

« Hide 'large scale' references
[1]"mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties."
Kang D.-C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B.
Proc. Natl. Acad. Sci. U.S.A. 99:637-642(2002) [PubMed: 11805321] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
Tissue: Melanoma.
[2]"A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication."
Cocude C., Truong M.-J., Billaut-Mulot O., Delsart V., Darcissac E., Capron A., Mouton Y., Bahr G.M.
J. Gen. Virol. 84:3215-3225(2003) [PubMed: 14645903] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, VARIANT ARG-843.
Tissue: Spleen.
[3]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANTS ARG-843 AND THR-946.
Tissue: Uterus.
[4]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 475-1025 (ISOFORM 1), VARIANTS ARG-843 AND THR-946.
[5]"Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation."
Kovacsovics M., Martinon F., Micheau O., Bodmer J.-L., Hofmann K., Tschopp J.
Curr. Biol. 12:838-843(2002) [PubMed: 12015121] [Abstract]
Cited for: MUTAGENESIS OF ASP-251 AND GLU-444, TISSUE SPECIFICITY.
[6]Erratum
Kovacsovics M., Martinon F., Micheau O., Bodmer J.-L., Hofmann K., Tschopp J.
Curr. Biol. 12:1633-1633(2002)
[7]"The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter."
Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., Randall R.E.
Proc. Natl. Acad. Sci. U.S.A. 101:17264-17269(2004) [PubMed: 15563593] [Abstract]
Cited for: INTERACTION WITH PARAMYXOVIRUSES V PROTEIN.
[8]"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction."
Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S.
Nat. Immunol. 6:981-988(2005) [PubMed: 16127453] [Abstract]
Cited for: INTERACTION WITH MAVS.
[9]"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus."
Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J.
Nature 437:1167-1172(2005) [PubMed: 16177806] [Abstract]
Cited for: INTERACTION WITH MAVS.
[10]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[11]"A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region."
Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., Guja C., Ionescu-Tirgoviste C., Widmer B., Dunger D.B., Savage D.A., Walker N.M., Clayton D.G., Todd J.A.
Nat. Genet. 38:617-619(2006) [PubMed: 16699517] [Abstract]
Cited for: VARIANT THR-946, ASSOCIATION WITH INSULIN-DEPENDENT DIABETES MELLITUS 19.
+Additional computationally mapped references.

Cross-references

Sequence databases

AF095844 mRNA. Translation: AAG34368.1.
AY017378 mRNA. Translation: AAG54076.1.
BC046208 mRNA. Translation: AAH46208.1.
BC078180 mRNA. Translation: AAH78180.1. Sequence problems.
BC111750 mRNA. Translation: AAI11751.1.
AK056293 mRNA. Translation: BAB71141.1. Different initiation.
IPIIPI00005577.
IPI00556546.
RefSeqNP_071451.2.
UniGeneHs.163173

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
2RQBNMR-A896-1025[»]
3B6EX-ray1.60A277-490[»]
3GA3X-ray1.45A893-1017[»]
ModBaseSearch...

PTM databases

PhosphoSiteQ9BYX4.

Genome annotation databases

EnsemblENSG00000115267. Homo sapiens. [Contig view]
GeneID64135.
KEGGhsa:64135.

Organism-specific databases

GeneCardsGC02M162831.
H-InvDBHIX0002549.
HGNCHGNC:18873. IFIH1.
HPAHPA002656.
MIM606951. gene.
610155. phenotype.
PharmGKBPA134889215.
GenAtlasSearch...

Phylogenomic databases

HOGENOMQ9BYX4.
HOVERGENQ9BYX4.
OMAQ9BYX4. ENEKFAE.

Gene expression databases

ArrayExpressQ9BYX4.
BgeeQ9BYX4.
CleanExHS_IFIH1.
GermOnlineENSG00000115267. Homo sapiens.

Family and domain databases

InterProIPR001315. CARD.
IPR014001. DEAD-like_N.
IPR001650. DNA/RNA_helicase_C.
IPR014021. Helicase_SF1/SF2_ATP-bd.
IPR006935. Restrct_endonuc_I_R/III_Res.
[Graphical view]
PfamPF00619. CARD. 1 hit.
PF00271. Helicase_C. 1 hit.
PF04851. ResIII. 1 hit.
[Graphical view]
SMARTSM00487. DEXDc. 1 hit.
SM00490. HELICc. 1 hit.
[Graphical view]
PROSITEPS50209. CARD. False negative.
PS51192. HELICASE_ATP_BIND_1. 1 hit.
PS51194. HELICASE_CTER. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio66034.
SOURCESearch...

Entry information

Entry nameIFIH1_HUMAN
AccessionPrimary (citable) accession number: Q9BYX4
Secondary accession number(s): Q2NKL6 expand/collapse secondary AC list , Q6DC96, Q86X56, Q96MX8, Q9H3G6
Entry history
Integrated into UniProtKB/Swiss-Prot: April 12, 2005
Last sequence update: March 20, 2007
Last modified: June 16, 2009
This is version 70 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 2

Human chromosome 2: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents